Genelux Corporation (GNLX)
NASDAQ: GNLX · IEX Real-Time Price · USD
1.710
-0.130 (-7.07%)
At close: Jul 2, 2024, 4:00 PM
1.750
+0.040 (2.34%)
After-hours: Jul 2, 2024, 7:42 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $58.74 million as of July 2, 2024. Its market cap has decreased by -93.03% in one year.
Market Cap
58.74M
Enterprise Value
41.49M
1-Year Change
-93.03%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $58.74M, a decrease of -58.54%. That is a compound annual growth rate of -45.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 49.70M | -86.72% |
| Dec 29, 2023 | 374.30M | 164.16% |
| Jan 26, 2023 | 141.69M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MDxHealth | 64.40M |
| Theratechnologies | 64.37M |
| Burning Rock Biotech | 64.33M |
| Monogram Orthopaedics | 63.97M |
| AN2 Therapeutics | 63.54M |
| Entera Bio | 63.04M |
| Gritstone bio | 62.97M |
| Pro-Dex | 62.74M |